01
Jul

Xenon Pharmaceuticals’ Teva-partnered treatment for osteoarthritis pain missed its goals in a Phase IIb trial, a failure the biotech believes won’t derail the drug’s development in other indications.

…read more

Source: Xenon’s Teva-partnered pain drug flunks a test in osteoarthritis

    

0 No comments